ICD-10 Coding for Eliquis(I48.0, I48.0U, I48.91)
Learn how to accurately code and document Eliquis use with ICD-10 codes, including primary conditions and adverse effects.
Complete code families applicable to Eliquis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| I48.91 | Unspecified atrial fibrillation | Use when documenting atrial fibrillation as the primary condition treated with Eliquis. |
|
| Z79.01 | Long-term (current) use of anticoagulants | Use as a secondary code to indicate long-term anticoagulant therapy. |
|
| T45.515A | Adverse effect of anticoagulants, initial encounter | Use for documenting adverse effects directly linked to Eliquis. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutEliquis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Eliquis.
Vague documentation of anticoagulant use
Impact
Clinical: Leads to unclear treatment plans., Regulatory: Increases risk of audit issues., Financial: May result in denied claims.
Mitigation
Use specific terms like 'Eliquis for chronic AFib'.
Using 'anticoagulation' without specifying the drug or indication
Impact
Reimbursement: May lead to incorrect DRG assignment., Compliance: Risk of non-compliance with CMS guidelines., Data Quality: Impacts accuracy of patient records.
Mitigation
Specify 'Eliquis for chronic nonvalvular atrial fibrillation' in documentation.
Unspecified codes
Impact
Use of unspecified codes can trigger audits.
Mitigation
Ensure documentation is specific and complete.